CSL (CMXHF) Price & Analysis

Compare

79 Followers

CMXHF Stock Chart & Stats

$104.58

$5.38(3.14%)

At close: Jan 08 4:00 PM EST

$104.58

$5.38(3.14%)

Day’s Range― - ―

52-Week Range$102.45 - $184.09

Previous CloseN/A

Volume29.00

Average Volume (3M)1.78K

Market Cap

$52.09B

Enterprise Value$64.05B

Total Cash (Recent Filing)$1.15B

Total Debt (Recent Filing)$12.58B

Price to Earnings (P/E)35.8

Beta0.37

Next Earnings

Aug 18, 2026

EPS Estimate

2.82

Next Dividend Ex-DateN/A

Dividend Yield2.48%

Share Statistics

EPS (TTM)4.03

Shares Outstanding485,151,400

10 Day Avg. Volume4,226

30 Day Avg. Volume1,785

Financial Highlights & Ratios

PEG Ratio1.90

Price to Book (P/B)3.94

Price to Sales (P/S)4.94

P/FCF Ratio29.97

Enterprise Value/Market Cap1.23

Enterprise Value/Revenue4.08

Enterprise Value/Gross Profit8.39

Enterprise Value/Ebitda12.45

Forecast

1Y Price Target

$156.71

Price Target Upside49.85% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering11

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Cash GenerationA 58% surge in free cash flow and strong cash conversion (operating cash flow to net income ~1.19) materially strengthen CSL's ability to self-fund R&D, execute buybacks and the planned Seqirus demerger. Durable cash generation improves strategic optionality and balance sheet resilience.

Margin SustainabilityConsistently high gross and operating margins reflect advantaged manufacturing and pricing in plasma-derived and recombinant therapies. Sustained margin levels support reinvestment, cushion against cyclical shocks, and enable profitable long-term growth even with slower top-line expansion.

Specialty Franchises & LaunchesGrowing specialty franchises (hemophilia +13%) and successful product launches like ANDEMBRY reinforce CSL's franchise-driven model. High-value, recurring therapies create durable revenue streams with higher stickiness and pricing power versus commodity products, supporting long-term profitability.

Bears Say

U.S. Policy & Pricing RiskRegulatory changes such as IRA Part D reform and potential MFN pricing create structural downside to U.S. pricing power. Given the U.S. is a core market, sustained policy-driven price pressure could compress margins, reduce cash flows, and force strategic repricing or cost responses over multiple years.

Seqirus Segment VolatilitySeqirus' dependence on seasonal vaccine cycles and tender-driven demand makes its revenue inherently volatile. Persistent softness in core markets undermines segment predictability; the planned demerger acknowledges structural underperformance and raises execution risk as an independent entity.

Competition In EU Iron MarketGeneric entrants eroding Ferinject's EU performance show some product lines are exposed to commoditization. This structural competitive pressure can lower volumes and prices, creating long-term margin headwinds unless CSL secures differentiation, pricing agreements, or new indications.

CSL News

CSL downgraded to Sector Perform from Outperform at RBC Capital

RBC Capital downgraded CSL (CMXHF) to Sector Perform from Outperform with a price target of A$176, down from...

10d ago

CSL Issues Unquoted Employee Incentive Rights

CSL ( ($AU:CSL) ) has provided an update. CSL Limited has notified the market of the issue of...

2d ago

CSL Updates Market on Progress of On-Market Share Buy-Back

An announcement from CSL ( ($AU:CSL) ) is now available. CSL Limited has provided an updated notification to...

2d ago

CSL Discloses Final Director Interest Notice as Paul McKenzie Steps Down

CSL ( ($AU:CSL) ) has provided an update. CSL Limited has announced that Paul McKenzie ceased to be...

11d ago

CSL Publishes Half-Year Results Presentation and Webcast Access

An update from CSL ( ($AU:CSL) ) is now available. CSL Limited has released slide materials for its...

11d ago

CSL Declares Interim USD 1.30 Dividend for Half-Year to December 2025

CSL ( ($AU:CSL) ) has issued an update. CSL Limited has declared an interim dividend of USD 1.30...

11d ago

CSL Earnings Hit by Impairments as Transformation Drive and Buy-Back Accelerate

CSL ( ($AU:CSL) ) has provided an announcement. CSL reported half-year underlying NPATA of US$1.9 billion, down 7%...

11d ago

CSL Profit Slumps 80% on Softer Revenue but Dividend Held Steady

The latest update is out from CSL ( ($AU:CSL) ). CSL Limited reported a weaker first half for...

11d ago

CSL names veteran executive Gordon Naylor interim CEO as Paul McKenzie retires

The latest update is out from CSL ( ($AU:CSL) ). CSL has announced the retirement of Chief Executive...

12d ago

CSL Reports Lapse of Nearly 60,000 Conditional Rights

The latest announcement is out from CSL ( ($AU:CSL) ). CSL Limited has notified the market that 59,992...

16d ago

CSL Sets Date for 2026 Half-Year Results and Investor Briefing

The latest announcement is out from CSL ( ($AU:CSL) ). CSL Limited has scheduled the release of its...

20d ago

CSL upgraded to Outperform from Sector Perform at RBC Capital

RBC Capital upgraded CSL (CMXHF) to Outperform from Sector Perform with a price target of A$230, up from...

1M ago

CSL upgraded to Buy from Hold at Canaccord

Canaccord analyst Shane Storey upgraded CSL (CSLLY) to Buy from Hold with a price target of A$225, down...

4M ago

CSL initiated with an Overweight at Morgan Stanley

Morgan Stanley initiated coverage of CSL (CSLLY) with an Overweight rating and A$313 price target A “solid revenue...

11M ago

CMXHF FAQ

What was CSL’s price range in the past 12 months?

CSL lowest stock price was $102.45 and its highest was $184.09 in the past 12 months.

What is CSL’s market cap?

CSL’s market cap is $52.09B.

When is CSL’s upcoming earnings report date?

CSL’s upcoming earnings report date is Aug 18, 2026 which is in 178 days.

How were CSL’s earnings last quarter?

CSL released its earnings results on Feb 10, 2026. The company reported $4.03 earnings per share for the quarter, missing the consensus estimate of $4.14 by -$0.11.

Is CSL overvalued?

According to Wall Street analysts CSL’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does CSL pay dividends?

CSL pays a Semiannually dividend of $1.613 which represents an annual dividend yield of 2.48%. See more information on CSL dividends here

What is CSL’s EPS estimate?

CSL’s EPS estimate is 2.82.

How many shares outstanding does CSL have?

CSL has 485,151,400 shares outstanding.

What happened to CSL’s price movement after its last earnings report?

CSL reported an EPS of $4.03 in its last earnings report, missing expectations of $4.14. Following the earnings report the stock price went down -4.697%.

Which hedge fund is a major shareholder of CSL?

Currently, no hedge funds are holding shares in CMXHF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

CSL Stock Smart Score

Neutral

Fundamentals

Return on Equity

16.36%

Trailing 12-Months

Asset Growth

3.63%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

CSL (CMXHF) Earnings & Revenues

Historic Earnings Reports

CMXHF Company Deck

CMXHF Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Neutral

CSL demonstrated strong financial growth and strategic initiatives, including successful product launches and plans to streamline operations and enhance R&D efficiency. However, challenges remain in the form of U.S. policy impacts, competitive pressures in the iron market, and a soft performance in the Seqirus segment.View all CMXHF earnings summaries

CMXHF Stock 12 Month Forecast

Average Price Target

$156.71

▲(49.85% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"114":"$114","165":"$165","216":"$216","139.5":"$139.5","190.5":"$190.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":215,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$215.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":156.71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$156.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":123.8825,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$123.88</span>\n  </div></div>","useHTML":true}}],"tickPositions":[114,139.5,165,190.5,216],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,124.37,131.34153846153848,138.31307692307692,145.2846153846154,152.25615384615384,159.2276923076923,166.19923076923078,173.17076923076922,180.1423076923077,187.11384615384617,194.0853846153846,201.05692307692308,208.02846153846156,{"y":215,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,124.37,126.85769230769232,129.34538461538463,131.83307692307693,134.32076923076923,136.80846153846156,139.29615384615386,141.78384615384616,144.27153846153846,146.75923076923078,149.24692307692308,151.73461538461538,154.2223076923077,{"y":156.71,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,124.37,124.33250000000001,124.295,124.25750000000001,124.22,124.1825,124.145,124.1075,124.07,124.0325,123.99499999999999,123.9575,123.91999999999999,{"y":123.8825,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":170.759,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.25,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":150.018,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.078,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.283,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":149.25,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.463,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.831,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.085,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.487,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.62,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.5,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.37,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 47, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >